Long-term oxygen treatment need is less frequent in eosinophilic COPD patients

被引:0
|
作者
Acet-Ozturk, Nilufer Aylin [1 ]
Dilektasli, Asli G. [1 ]
Aydin-Guclu, Ozge [1 ]
Demirdogen, Ezgi [1 ]
Coskun, Funda [1 ]
Ursavas, Ahmet [1 ]
Karadag, Mehmet [1 ]
Uzaslan, Esra [1 ]
机构
[1] Uludag Univ, Fac Med, Dept Pulmonol, TR-16120 Bursa, Turkey
来源
CLINICAL RESPIRATORY JOURNAL | 2022年 / 16卷 / 01期
关键词
COPD; eosinophil; inflammation; supplemental oxygen; OBSTRUCTIVE PULMONARY-DISEASE; BLOOD EOSINOPHILS; HOSPITALIZED EXACERBATIONS; AIRWAY INFLAMMATION; TURKISH VERSION; COUNT; BECLOMETHASONE/FORMOTEROL; RELIABILITY; PREVALENCE; STABILITY;
D O I
10.1111/crj.13451
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction Eosinophilic airway inflammation is a recognized inflammatory pattern in subgroups of patients with chronic obstructive pulmonary disease (COPD). However, there are still conflicting results between various studies concerning the effect of eosinophils in COPD patients. Our aim with this study was to evaluate eosinophilic inflammation and its relation to the clinical characteristics in a group of COPD patients. Methods Stable COPD patients with FEV1% predicted < 50 or with >= 1 exacerbation leading to hospital admission or >= 2 moderate or severe exacerbation history were consecutively enrolled from outpatient clinics. Results We included 90 male COPD patients, with a mean age of 63.3 +/- 9.2. Mean FEV1% predicted was 35.9 +/- 11.3. Eosinophilic inflammation (eosinophil percentage >= 2%) was evident in 54 (60%) of the patients. Participants with eosinophilic inflammation were significantly older and had better FEV1 predicted % values. Eosinophilic COPD patients were characterized with better quality of life and fewer symptoms. COPD patients with noneosinophilic inflammation used supplemental long-term oxygen therapy (LTOT) more frequently compared to patients with eosinophilic inflammation (36.1% vs. 14.8%, p = 0.01). Eosinophilic inflammation is associated with less dyspnea severity measured by mMRC (OR: 0.542 95% CI: 0.342-0.859, p = 0.009) and less LTOT use (OR: 0.334 95% CI: 0.115-0.968, p = 0.04) regardless of age, severity of airflow limitation, and having frequent exacerbation phenotype. Conclusion Our study supports the growing evidence for a potential role of eosinophilic inflammation phenotype in COPD with distinctive clinical characteristics. Eosinophilic inflammation is inversely associated with dyspnea severity measured by mMRC and LTOT use independently from age, total number of exacerbations, St. George Respiratory Questionnaire (SGRQ) total score and FEV1% predicted.
引用
收藏
页码:49 / 56
页数:8
相关论文
共 50 条
  • [31] The impact of the Danish Oxygen Register on adherence to guidelines for long-term oxygen therapy in COPD patients
    Ringbaek, TJ
    Lange, P
    RESPIRATORY MEDICINE, 2006, 100 (02) : 218 - 225
  • [32] Long-term oxygen therapy in COPD: what is the evidence?
    Windisch, Wolfram
    Magnet, Friederike Sophie
    LANCET RESPIRATORY MEDICINE, 2022, 10 (11): : 1010 - 1011
  • [33] Left Ventricular Diastolic Dysfunction In COPD Patients On Long Term Oxygen Treatment
    Desai, P.
    Ciccolella, D.
    Grabianowski, C. L.
    Criner, G. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [34] Making Long-Term Oxygen Therapy Less Burdensome
    Taichman, Darren B.
    Drazen, Jeffrey M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (11): : 1050 - 1051
  • [35] Long-term treatment of COPD - Is there anything new?
    Weitzenblum, E
    REVUE DES MALADIES RESPIRATOIRES, 2003, 20 (05) : S32 - S34
  • [36] Effects of long-term treatment with corticosteroids in COPD
    Renkema, TEJ
    Schouten, JP
    Koeter, GH
    Postma, DS
    CHEST, 1996, 109 (05) : 1156 - 1162
  • [37] Long-Term Budesonide Maintenance Treatment Is Partially Effective for Patients With Eosinophilic Esophagitis
    Straumann, Alex
    Conus, Sebastien
    Degen, Lukas
    Frei, Cornelia
    Bussmann, Christian
    Beglinger, Christoph
    Schoepfer, Alain
    Simon, Hans-Uwe
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (05) : 400 - U1401
  • [38] Genomics and Response to Long-Term Oxygen Treatment in COPD: The LOTT Pharmacogenomics Ancillary Study
    Seo, M.
    Qiu, W.
    Bailey, W. C.
    Criner, G. J.
    Dransfield, M. T.
    Fuhlbrigge, A. L.
    Reilly, J. J.
    Scholand, M. B.
    Silverman, E. K.
    Hersh, C. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [39] Long-term nasal high flow treatment with oxygen in COPD - exacerbations, admissions and mortality
    Weinreich, Ulla
    Storgaard, Line
    Hockey, Hans
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [40] No Maintenance, No Gain in Long-term Treatment of Eosinophilic Esophagitis
    Dellon, Evan S.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (03) : 397 - 399